InstantGMP™, a provider of cloud-based GMP and FDA compliance software for pharmaceutical and other regulated manufacturers, announced it has aligned its software development and validation practices ...
Risk is a lens, not a leash. Once teams see what truly threatens patients and processes, the busywork falls away, and quality ...
DUBLIN--(BUSINESS WIRE)--"Implementing CSA for GxP Systems - Transition, Documentation, and Post-Transition Challenges and Opportunities" training has been added to ResearchAndMarkets.com's ...
The FDA recently had a meeting to explore regulatory aspects of AI-enabled mental health medical devices. I explore a useful ...
Pearl, the global leader in AI solutions for dentistry, today announced that the U.S. Food and Drug Administration (FDA) has ...
HeartSciences Inc.(Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT” ...
The FDA's scrutiny of WHOOP highlights increasing challenges for niche wearable device makers as they navigate regulatory hurdles and compliance costs in a booming fitness technology market.
HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the ...
Bioassay variability can pose significant challenges due to laboratory conditions, instrumentation, analytical software, cell ...
The agency’s sweeping rollout and staff challenge underscore rising momentum behind agentic AI: advanced, multiagent systems now fueling early pilots in medical writing, patient engagement and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback